Bellevue Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bellevue Group’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-375,000	Closed	-$4.67M	–	137
2016 Q4	$4.67M	Sell	375,000 -120,000	-24%	-$1.45M	0.96%	35
2016 Q3	$6.78M	Hold	495,000	–	–	1.22%	30
2016 Q2	$3.66M	Hold	495,000	–	–	0.69%	46
2016 Q1	$3.16M	Buy	+495,000	New	+$2.77M	0.57%	58

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Bellevue Group's ARIA Position: Q1 2017 in Review

Bellevue Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 375,000 shares — an estimated $4.67M sold.

Bellevue Group first reported a position in ARIA in Q1 2016 and held it in 4 quarters. The position peaked at $6.78M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Bellevue Group reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Bellevue Group sold 375,000 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $4.67M.
Bellevue Group first reported a position in Ariad Pharmaceuticals Inc in Q1 2016 and held it in 4 quarters.
Bellevue Group's Ariad Pharmaceuticals Inc position peaked at $6.78M in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Bellevue Group's 13F filing for Q1 2017, filed 11 May 2017.